TriSalus Life Sciences, Inc. Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- TriSalus Life Sciences, Inc. payments for repurchase of warrants for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- TriSalus Life Sciences, Inc. payments for repurchase of warrants for fiscal 2023 was $20.00K.
- TriSalus Life Sciences, Inc. payments for repurchase of warrants for fiscal 2022 was $0.00.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2024-12-31 | $0.00 10-K/A · filed 2025-05-30 | |
| 2023-12-31 | $20.00K 10-K/A · filed 2025-05-30 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-11 | |
| 2021-12-31 | $9.08M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |